AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Short Interest Up 312.9% in April

Posted by Stephan Jacobs on May 13th, 2026

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totaling 79,118 shares, an increase of 312.9% from the April 15th total of 19,163 shares. Based on an average daily trading volume, of 104,102 shares, the days-to-cover ratio is currently 0.8 days. Currently, 4.8% of the shares of the stock are sold short.

AdvisorShares Psychedelics ETF Price Performance

Shares of AdvisorShares Psychedelics ETF stock traded up $0.62 on Wednesday, hitting $20.55. The company’s stock had a trading volume of 29,346 shares, compared to its average volume of 28,777. AdvisorShares Psychedelics ETF has a 52-week low of $11.52 and a 52-week high of $22.49. The firm has a fifty day moving average price of $18.00 and a 200-day moving average price of $17.92.

Institutional Trading of AdvisorShares Psychedelics ETF

An institutional investor recently raised its position in AdvisorShares Psychedelics ETF stock. CIBC Private Wealth Group LLC lifted its holdings in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) by 18.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,566 shares of the company’s stock after purchasing an additional 4,547 shares during the period. CIBC Private Wealth Group LLC owned about 2.51% of AdvisorShares Psychedelics ETF worth $508,000 as of its most recent SEC filing.

About AdvisorShares Psychedelics ETF

(Get Free Report)

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.